Protenium Clinical Research, LLC   Report issue

For profit Phase 2
Founded: Hurst TX United States (2009)
Status: Acquired by Elligo Health Research (2019)

Organization Overview

First Clinical Trial
2013
NCT01819272
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree